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South-East Asian ovalocytosis (SAO) is caused by the heterozygous presence of a variant form of the human erythrocyte anion transporter (band 
3; AEl). The expression of band 3 SAO has been studied in Xenopus oocytes. Band 3 SAO is not functional as an anion transporter but is inserted 
stably into the plasma membrane of oocytes. Band 3 SAO translocation to the cell surface does not require co-expression of normal band 3. 
Co-expression of glycophorin A @PA) increases the rate of translocation of band 3 SAO to the oocyte membrane but is not essential for this process. 
We suggest hat the increased tendency of band 3 SAO to form oligomers may facilitate its translocation to the cell surface. 
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1. INTRODUCTION 
South-East Asian hereditary ovalocytosis (SAO) is 
common in some areas of Melanesia where malaria is 
endemic and is caused by the heterozygous presence of 
an abnormal band 3 [l]. The amino acid sequence of 
band 3 SAO has recently been determined from the 
cDNA sequence [2-51 and shown to contain a deletion 
of nine amino acid residues corresponding to part of the 
first transmembrane domain of normal band 3. SAO 
erythrocytes are more rigid than normal cells and show 
increased resistance to malarial parasite invasion. These 
red cells exhibit about half the anion transport activity 
of normal red cells which suggests that the mutant band 
3 is defective for anion transport [6]. Band 3 SAO does 
not bind stilbene disulphonates [6], which inhibit band 
3-mediated anion transport, and it lacks the polylacto- 
saminyl oligosaccharide found on normal band 3 [7]. 
These findings suggest hat the structure of the whole 
membrane domain of band 3 SAO is disrupted. 
Expression of normal band 3 in Xenopus oocytes in- 
duces chloride transport in the cells that is inhibitable 
with 4,4’-dinitrostilbene-2,2’-disulphonate (DNDS). In 
contrast, injection of band 3 SAO cRNA into oocytes 
does not induce any stilbene-disulphonate sensitive 
chloride transport activity [9]. However, in these exper- 
iments it was not established whether the absence of Cl- 
transport activity resulted from the band 3 SAO not 
being translocated to the cell surface and therefore not 
being expressed there, or from the band 3 SAO protein 
being intrinsically inactive for anion transport. It could 
also be that co-expression of normal band 3 is required 
for the translocation of band 3 SAO to the plasma 
membrane. 
In this work, we have examined whether band 3 SAO, 
expressed from the cRNA in oocytes, is translocated to 
the plasma membrane of the oocyte. We have also ex- 
amined whether, like normal band 3, the movement of 
band 3 SAO to the cell surface is facilitated by GPA. 
Normal band 3 associates in the membrane to form 
a mixture of dimers and tetramers. The tetramers are 
thought to interact preferentially with the cytoskeleton 
[8]. Band 3 SAO has a greater tendency to form tetra- 
mers relative to dimers than normal band 3 [7]. This 
could, at least in part, account for the increased rigidity 
of ovalocytic cells. 
2. MATERIALS AND METHODS 
*Corresponding author. Fax: (44) (272) 303 497. 
Abbreviations: BADS, 4-benzamido-4’-aminostilbene-2,2’-disulpho- 
nate; DIDS, 4,4’-diisothiocyanato-2,2’-stilbene disulphonate; DNDS, 
4,4’-dinitrostilbene-2,2’-disulphonate; GPA, glycophorin A; SAO, 
South-East Asian hereditary ovalocytosis. 
The cDNA clones encoding human band 3 @BSXGl.b3) and glyco- 
phorin A (pBSXG.GPA) have been described previously [lo]. The 
cDNA coding for band 3 SAO [5] was constructed from pBSXGl.b3 
by oligonucleotide-directed mutagenesis (Amersham kit). Amino acid 
residues 400-408 of the band 3 coding sequence were deleted using 
the oligonucleotide S-CTGAGTGACATCACAGATGTCATC’IT- 
CATCTACTTTG-3’ to give pBSXGlSA0. 
Protocols for synthesis of cRNA, oocyte isolation and cRNA injec- 
tion, 35S-amino acid labelling, immunoprecipitation of band 3, chy- 
motrypsin treatment of oocytes and chloride influx assays in oocytes 
have all been described [lo]. The anti-band 3 monoclonal antibodies 
used were BRIC 155, which is directed against the cytoplasmic C- 
terminus of band 3 [ll] and BRIC 6, which is directed against an 
extracellular epitope in the membrane domain of band 3 (supplied by 
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Dr. D.J. Anstee, International Blood Group Reference Laboratory, 
Bristol, UK). 
3. RESULTS 
The 9 amino acid residue deletion in band 3 SAO has 
been suggested to cause the protein to mis-fold in the 
membrane so that it does not support any anion trans- 
port activity [6]. In this work we examined whether the 
inability of band 3 SAO cRNA to induce DNDS-sensi- 
tive chloride transport activity in Xenopus oocytes [9] 
might be due to an inability of this protein to be translo- 
cated to the oocyte plasma membrane. The expression 
of normal band 3 at the cell surface of oocytes is facili- 
tated by the co-expression of glycophorin A (GPA) [lo] 
and we investigated whether this effect is also observed 
with band 3 SAO. The cRNAs coding for normal and/ 
or band 3 SAO were injected into oocytes, with or with- 
out GPA cRNA (1.5 ng each/oocyte). The presence of 
both normal and band 3 SAO at the cell surface was 
studied using two approaches. 
In a first experiment, groups of intact oocytes were 
treated with the monoclonal antibody BRIC 6 (which 
recognizes an extracellular epitope on band 3). Band 3 
was then immunoprecipitated from oocytes which were 
solubilized in buffer containing Triton X-100 as the only 
detergent. More band 3 was immunoprecipitated from 
oocytes in which both normal band 3 and GPA were 
co-expressed than those expressing band 3 alone (Fig. 
1, lanes A and B), as observed previously [lo]. However, 
band 3 SAO was not immunoprecipitated in either the 
presence or absence of GPA (Fig. 1, lanes C and D). To 
confirm that similar amounts of both normal and band 
3 SAO had been synthesized by the oocytes, the homo- 
genates were also immunoprecipitated with the mono- 
clonal antibody BRIC 155 (which recognizes the cyto- 
plasmic COOH-terminus of band 3) (Fig. 1, lanes E-H). 
These results suggested either that band 3 SAO is not 
translocated to the plasma membrane of oocytes or that 
BRIC 6 is not able to bind to the variant band 3 in the 
plasma membrane of oocytes. 
To resolve this question, a second experiment was 
performed in which the expression of both normal band 
3 and band 3 SAO in the plasma membrane of oocytes 
was assessed by an independent method. Band 3 in red 
cells is cleaved by chymotrypsin at its extracellular sur- 
face to yield an N-terminal 60 kDa and a C-terminal 
35-kDa fragment [12] and chymotrypsin treatment has 
been used previously to probe for normal band 3 ex- 
pressed at the surface of oocytes [lo]. Groups of 15 
oocytes were injected with normal band 3 cRNA, band 
3 SAO cRNA and GPA cRNA in different combina- 
tions. Oocytes were pulse-labelled with 35S-labelled 
amino acids and then subjected to a chase with unla- 
belled amino acids for 48 h. Some of the groups of 
oocytes were treated with chymotrypsin for 1 h at 4°C. 




Fig. 1. Immunoprecipitation of oocyte surface band 3 with BRIC 6. 
Groups of 10 oocytes were injected with either 1.5 ngloocyte of band 
3 cRNA (lanes A,B,E and F) or 1.5 ng/oocyte of band 3 SAO cRNA 
(lanes C,D,G and H) Some were co-injected with 1.5 ng/oocyte GPA 
cRNA (lanes B,D,F and H). Oocytes were pulse-labelled with “S- 
labelled amino acids and chased with unlabelled amino acids for 48 
h. The intact cells were treated with the monoclonal antibody BRIC 
6 (which is directed against an extracellular epitope on band 3), 
washed free from antibody and homogenized. Surface band 3 was 
assessed in one half of the homogenate by immunoprecipitation of 
bound BRIC 6 (lanes A-D) as detailed in reference [lo]. To conIirm 
that band 3 had been expressed equally in all four sets of injected 
oocytes, BRIC 155 (reactive with the cytoplasmic CGGH terminus of 
band 3) was added to the second half of the homogenate and total 
band 3 was immunoprecipitated (lanes E-H). Each lane represents 
immunoprecipitated protein from the equivalent of 5 oocytes, sepa- 
rated on 10% SDS-PAGE. 
oocytes were then incubated with BRIC 6 overnight at 
4°C to allow the antibody to react with surface band 3. 
After removal of excess antibody by washing in Barths 
saline, groups of ten BRIC 6-treated oocytes were ho- 
mogenized in Triton X-100 immunoprecipitation buffer 
(with no SDS present) and each homogenate was di- 
vided into three equal portions. The surface band 3 to 
which the BRIC 6 had bound during the earlier incuba- 
tion with the intact oocytes was immunoprecipitated 
from one of the portions by addition of protein A- 
Sepharose (Fig. 2a). The total band 3 present in the 
oocyte homogenates was imrnunoprecipitated from 
each of the remaining portions by addition of either 
BRIC 6 (Fig. 2b) or BRIC 155 (Fig. 2c), followed by 
protein A-Sepharose. 
When groups of intact oocytes were treated with 
BRIC 6 (without prior chymotrypsin digestion) and sur- 
face band 3 was subsequently immunoprecipitated, nor- 
mal band 3 but not band 3 SAO was detected (Fig. 2a). 
These results are similar to those in Fig. 1. When im- 
munoprecipitation of surface band 3 from chymotryp- 
sin-treated intact oocytes was attempted using BRIC 6, 
neither normal nor band 3 SAO were detected (Fig. 2a). 
This suggests that the BRIC 6 epitope of normal band 
3 is destroyed by digestion of intact oocytes with chy- 
motrypsin and confirms that the cleavage of surface 
band 3 was complete. The BRIC 6 epitope on band 3 
is lost when red cells are treated with chymotrypsin (Dr. 
D.J. Anstee, personal communication). 
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Fig. 2. Immunoprecipitation of normal and South-East Asian ovalo- 
cytic band 3 from chymotrypsin-treated oocytes. Groups of 10 oocytes 
were injected with 1.5 ng of the cRNAs corresponding to normal band 
3 (B3), ovalocytic band 3 (SAO) and GPA (A) in different combina- 
tions as indicated. Cells were pulse-labelled with 35S-labelled amino 
acids and chased with unlabelled amino acids for 48 h. The intact 
oocytes were incubated for 1 h at 4°C with or without chymotrypsin, 
and then treated with BRIC 6 for 18 h at 4’C. All oocytes were 
homogenized and equal portions of the homogenate were incubated 
with either (a) no further antibody; (b) BRIC 6 or (c) BRIC 155. Band 
3 was then immunoprecipitated from all the samples using Protein 
A-Sepharose CL4B. Each lane represents immunoprecipitated pro- 
tein from the equivalent of 334 oocytes, separated on 11% SDS- 
PAGE. The faint bands which are also visible in the GPA-injected 
oocyte samples are due to low level non-specific precipitation of other 
proteins. The position of the COOH-terminal35-kDa band 3 fragment 
is indicated. The proportion of band 3 cleaved by chymotrypsin was 
determined by scanning densitometry of the SDS-PAGE fluorogra- 
phs. Expressed protein was estimated from the areas under the peaks. 
The 35kDa band 3 fragment was assumed to contain 60% of the 
radioactivity incorporated into intact band 3, based on methionine 
and cysteine content. Values are percentage of total band 3 (i.e. intact 
+ fragment) which was found as the 35-kDa fragment. Chloride influx 
(60 min) was measured 24 h after injection of cRNAs. The mean 
DNDS-sensitive chloride influx was determined for each of the cRNA 
mixtures from the difference between the means of groups of 10-12 
oocytes which were not treated with chymotrypsin and were assayed 
with and without 400 ,uM DNDS treatment. 
+ 
When intact oocytes that had been treated with BRIC 
6 were subsequently homogenized in the presence of 
Triton X-100 and then immunoprecipitated using a sec- 
ond addition of BRIC 6, both normal band 3 and band 
3 SAO were detected (Fig. 2b). Since the action of chy- 
motrypsin on surface band 3 destroys the BRIC 6 epi- 
tope, only intact (intracellular) band 3 was immunopre- 
cipitated from chymotrypsin-treated oocytes. It appears 
that BRIC 6 immunoprecipitates Triton-solubilized 
SAO and normal band 3 in oocyte homogenates but 
that the antibody binds only to normal band 3 at the 
surface of intact oocytes. 
Both normal band 3 and band 3 SAO were detected 
in the immunoprecipitates from Triton-solubilized 
oocyte homogenates using BRIC 155 (Fig. 2~). Im- 
munoprecipitates from the chymotrypsin-treated 
oocytes contained both intact (intracellular) band 3 and 
the 35kDa chymotryptic fragment of band 3, which is 
derived from band 3 at the cell surface. Both normal 
band 3 and band 3 SAO were cleaved by chymotrypsin. 
This shows that band 3 SAO is translocated to the 
plasma membrane of oocytes and that this takes place 
without co-expression of either GPA or normal band 3. 
A greater proportion of band 3 SAO was cleaved by 
chymotrypsin in oocytes in which GPA was co-ex- 
pressed than those in which band 3 SAO cRNA was 
expressed alone. This observation was confirmed in a 
second experiment (data not shown) and indicates that 
GPA facilitates the translocation of band 3 SAO to the 





SAO - - - + + + - + 
GPA - + + - + + + + 
Chymotrwsin I + I + I + I + I + I + I - I - 
a 
cRNAs 
B3 + - + - - + + - 
injected 
SAO - - - + + + - + 
GPA - + + - + + + + 
Chymohypsin I + I + I + I + I + I + I - I - I 
b 
cRNAs 
83 + - + - - + + - 
injected 
SAO - - - + + + - + 
GPA - + + - + + + + 




When equivalent concentrations of either band 3 
SAO or normal band 3 cRNAs are expressed in oocytes, 
a greater proportion of band 3 SAO is cleaved by chy- 
motrypsin than in the corresponding oocytes expressing 
normal band 3 (Fig. 2~). This effect was observed 
whether or not GPA was present and suggests that band 
3 SAO is translocated to the oocyte surface more readily 
than normal band 3. 
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The DNDS-sensitive chloride influx into oocytes was 
also measured 24 h after injection of the cRNAs using 
parallel sets of oocytes that had not been treated with 
chymotrypsin (Fig. 2~). The levels of anion transport 
were similar to those observed previously in each case 
[9]. Co-expression of normal band 3, band 3 SAO and 
GPA resulted in a slightly lower level of chloride trans- 
port than co-expression of normal band 3 and GPA. 
This could be due to a reduction in the amount of 
normal band 3 synthesized (due to competition between 
the cRNAs) when band 3 SAO and GPA cRNAs are 
also expressed at the surface. Alternatively, hetero-oli- 
gomers of normal band 3 and band 3 SAO may be 
formed, and the rate of chloride transport by normal 
band 3 may be reduced in these hetero-oligomers. 
4. DISCUSSION 
We have shown that band 3 SAO is expressed at the 
plasma membrane of oocytes in both the presence and 
absence of GPA. However, anion transport was not 
detected in parallel sets of oocytes that were injected 
with the same cRNAs as were used to study cell surface 
expression (Fig. 2~). This confirms that, when expressed 
in oocytes, the lack of anion transport in band 3 SAO 
is caused by loss of the ability of the band 3 SAO protein 
to transport chloride and not by the lack of movement 
of band 3 SAO to the cell surface. 
All known individuals with hereditary ovalocytosis 
are heterozygous for SAO and normal band 3, and the 
homozygous condition is presumed to be lethal. We 
have found that band 3 SAO is translocated to the 
plasma membrane of oocytes without requiring the co- 
expression of normal band 3. This implies that the for- 
mation of a heterodimer between band 3 SAO and nor- 
mal band 3 is not essential for band 3 SAO to move to 
the cell surface. 
In band 3 SAO, the deletion of amino acid residues 
40&408 of normal band 3, which are located at the 
boundary of the N-terminal cytoplasmic domain and 
first transmembrane helix of normal band 3, affects 
several properties associated with the extracellular sur- 
face of band 3. The anion transport inhibitors 4,4’- 
diisothiocyanato-2,2’-stilbene disulphonate (DIDS) [6], 
and 4-benzamido-4’-aminostilbene-2,2’-disulphonate 
(BADS) [7] do not bind to band 3 SAO and the forma- 
tion of the polylactosaminyl oligosaccharide on the ex- 
tracellular side of the mutant band 3 is prevented. We 
have found that the monoclonal antibody BRIC 6, 
(which reacts with an extracellular epitope on band 3) 
does not immunoprecipitate band 3 SAO expressed in 
the plasma membranes of intact oocytes, whereas it 
reacts with normal band 3 under these conditions. This 
demonstrates that the folded structure of cell surface 
band 3 SAO in the region of the BRIC 6 epitope is 
different from that of normal band 3 and suggests that 
the BRIC 6 epitope is concealed or misfolded in native 
band 3 SAO, even though the antibody binding site is 
distal from the band 3 SAO deletion in the amino acid 
sequence. However, when the oocyte membranes are 
solubilized using the detergent Triton X-100, both nor- 
mal band 3 and band 3 SAO are immunoprecipitated 
using BRIC 6. One possible explanation for these unex- 
pected results is that the structures of intracellular and 
cell surface band 3 SAO are different, and that BRIC 
6 binds more strongly to the intracellular form. Altema- 
tively, BRIC 6 may bind to band 3 SAO with a lower 
affinity than to normal band 3. In this case, the higher 
concentration of band 3 present in the oocyte homoge- 
nates may allow detection of the band 3 SAO in the 
immunoprecipitates. 
Although the folding of some regions of the band 3 
molecule are severely affected by the SAO deletion, it 
appears that these effects may be local, and that the 
global structure of band 3 SAO is similar to that of 
normal band 3. The circular dichroism spectra of nor- 
mal and band 3 SAO are comparable, when either the 
intact proteins or the isolated membrane domain is used 
[7], and the mutant protein is expressed stably in both 
ovalocytic red cells and Xenopus oocytes. Previous at- 
tempts to separate normal band 3 and band 3 SAO by 
lectin or inhibitor affinity chromatography were not 
successful [7], which suggests that SAO and normal 
band 3 may be able to associate to form hetero-oligom- 
ers. We have found that band 3 SAO interacts with 
GPA in internal membranes of oocytes to facilitate the 
translocation of band 3 SAO to the plasma membrane, 
similarly to normal band 3 [lo]. This shows that those 
regions of the band 3 molecule that are responsible for 
this GPA-dependent effect are not disrupted in band 3 
SAO and provides further evidence that certain aspects 
of the overall structure of normal band 3 are conserved 
in band 3 SAO. 
Band 3 from SAO erythrocytes has been shown previ- 
ously to contain a higher proportion of tetramers rela- 
tive to dimers than normal band 3 [7]. We have shown 
that a higher proportion of band 3 SAO is expressed at 
the surface of oocytes than normal band 3, and that this 
difference is independent of the presence of GPA. It is 
possible that the increased tendency of band 3 SAO to 
form oligomers encourages formation of a structure 
that is more readily translocated to the oocyte surface. 
This is consistent with the previous suggestion that oli- 
gomerization of band 3 may be required for the efficient 
translocation of band 3 to the cell surface. 
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